Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co.
Community/Retail Pharmacy
1030 W Martin Luther King Jr Blvd, Suite 104, Los Angeles
California, 90037-1871
323-235-5800 323-235-5885
Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. is a Community/Retail Pharmacy in Los Angeles, California. This organization is also known as sub part of Biotech Pharmaceuticals, Inc.. It is located at 1030 W Martin Luther King Jr Blvd, Suite 104, Los Angeles and it's customer support contact number is 323-235-5800. The authorized person of Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. is Cheryl Turner who is General Manager of the pharmacy and his contact number is 323-235-5800. Active license number of Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. is PHA 442540 for Community/Retail Pharmacy in California.
Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. |
| Type: | Community/Retail Pharmacy |
| Location: | 1030 W Martin Luther King Jr Blvd, Suite 104, Los Angeles,
California, 90037-1871 |
| Phone: | 323-235-5800 |
| Fax: | 323-235-5885 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Cheryl Turner |
| Position: | General Manager |
| Contact Number: | 323-235-5800 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1548342736 |
| Parent Organization: | Biotech Pharmaceuticals, Inc. |
| NPI Enumeration Date: | 19 Oct, 2006 |
| NPI Last Update On: | 01 May, 2009 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | PHA 442540 | California | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1030 W Martin Luther King Jr Blvd, Suite 104
Los Angeles, California |
| Zip: | 90037-1871 |
| Phone Number: | 323-235-5800 |
| Fax Number: | 323-235-5885 |
Patients can reach Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. at
1030 W Martin Luther King Jr Blvd, Suite 104, Los Angeles, California or can
call on customer care at 323-235-5800.
Comments/ Reviews:
Read all the reviews posted for Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co. below. You may also share your own experience with Biotech Pharmaceuticals, Inc., Dba Mckay Monkman Drug & Surgical Co.. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.